Ruthenium(II) Complex Incorporated UiO-67 Metal–Organic Framework Nanoparticles for Enhanced Two-Photon Fluorescence Imaging and Photodynamic Cancer Therapy

Rui Chen, Jinfeng Zhang, Jipsa Chelora, Yuan Xiong, Stephen V. Kershaw, King‐Fai Li, Pik Kwan Lo, Andrey L. Rogach, Juan Antonio Zapien, Chun‐Sing Lee

ACS Applied Materials & Interfaces · 2017 · 169 citations · 38 references

Concepts

Abstract

Ruthenium(II) tris(bipyridyl) cationic complex (Ru(bpy) 3 2+ ) incorporated UiO-67 (Universitetet i Oslo) nanoscale metal–organic frameworks (NMOFs) with an average diameter of ∼92 nm were developed as theranostic nanoplatform for in vitro two-photon fluorescence imaging and photodynamic therapy. After incorporation into porous UiO-67 nanoparticles, the quantum yield, luminescence lifetime, and two-photon fluorescence intensity of Ru(bpy) 3 2+ guest molecules were much improved owing to the steric confinement effect of MOF pores. Benefiting from these merits, the as-synthesized nanoparticles managed to be internalized by A549 cells while providing excellent red fluorescence in cytoplasm upon excitation with 880 nm irradiation. Photodynamic therapeutic application of the Ru(bpy) 3 2+ -incorporated UiO-67 NMOFs was investigated in vitro. The Ru(bpy) 3 2+ -incorporated UiO-67 NMOFs exhibited good biocompatibility without irradiation while having good cell-killing rates upon irradiation. In view of these facts, the developed Ru(bpy) 3 2+ -incorporated NMOFs give a new potential pathway to achieve enhanced two-photon fluorescence imaging and photodynamic therapy.

References

38